Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 64, Issue 5, 2005, Pages 784-786

  Rowshani, A T ^a   Remans, P ^a   Rozemuller, A ^a   Tak, P P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HALOPERIDOL; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE;

ADULT; ANTIGEN BINDING; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; BRAIN VASCULITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CRITHIDIA TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HEADACHE; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; MENTAL CONCENTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; RARE DISEASE; SENSITIVITY AND SPECIFICITY; SOMNOLENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ANTIBODIES, ANTIPHOSPHOLIPID; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 17644413264     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.026542     Document Type: Article

References (10)

1. Koerner C, Sommer C, Knauth M, Breitbart A, Wildemann B. Granulomatous cerebral vasculitis in systemic lupus erythematosus during systemic remission of disease. J Neurol 2000;247:722-4.
2. ACR. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
3. Weiner DK, Allen NB. Large vessel vasculitis of the central nervous system in systemic lupus erythematosus: report and review of the literature. J Rheumatol 1991;18:748-51.
4. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999;8:127-33.
5. Moroni PL, Raschi E, Camera M, Testoni C, Nicoletti F, Tincani A, et al. Endothelial activation by oPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 2000;15:237-40.
6. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
7. Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N. The recognition, diagnosis and management of cerebral vasculitis: a European survey. Eur J Neurol 2002;9:343-7.
8. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-63.
9. Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatrie lupus. J Rheumatol 1999;26:432-9.
10. Stojanovich L, Stojanovich R, Kostich V, Dziolich E. Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study). Lupus 2003;12:3-7.